University lands deal foritsdrug The University of Aberdeen has landed a deal which scientists claim could help to revolutionise the treatment of rheumatoid arthritis.

From: Aberdeen Evening Express | Date: October 16, 2007 | Copyright information

The University of Aberdeen has landed a deal which scientists claim could help to revolutionise the treatment of rheumatoid arthritis.

A team of researchers at the university have found a new drug they say could aid suffers.

Today it was revealed the scientists had signed a deal with drug development company Modern Biosciences.

It is now expected that clinical trials of the drug will start within two years.

Dr Iain Greig, medicinal chemist at the university, said:...

Read all of this article with a FREE trial to HighBeam Research

Related newspaper, magazine, and journal articles from HighBeam Research

University lands deal foritsdrug The University of Aberdeen has landed a deal which scientists claim could help to revolutionise the treatment of rheumatoid arthritis.
Aberdeen Evening Express ; ... Modern Biosciences is working with premier league research institutions. "We create value for their projects by applying our clinical development and project management expertise through to the stage of proof-of-concept in man." ee.news@ajl.co.uk
Diagnosis and management of rheumatoid arthritis.
American Family Physician ; Rheumatoid arthritis is a chronic inflammatory disease characterized by uncontrolled proliferation of synovial tissue and a wide array of multisystem comorbidities. Prevalence is estimated to be 0.8 percent worldwide, with women twice as likely to develop the disease as men. Untreated, 20 to 30
Diagnosing rheumatoid arthritis: current criteria.
American Family Physician ; Rheumatoid arthritis is a chronic, systemic inflammatory connective tissue disease of unknown etiology. It affects mainly synovial joints, resulting in relatively symmetric, polyarticular involvement. Arthritis may be mild and relapsing, or it may be severe and progressive, leading to joint
MANAGEMENT OF RHEUMATOID ARTHRITIS.(TRIAD)
The News & Record (Piedmont Triad, NC) ; Byline: Robert M. Gay< Special to the News & Record Rheumatoid arthritis (RA) is a relatively common disease in which the lining or membranes of joints become inflamed ...
Rheumatoid arthritis: what you should know.(Information from Your Family Doctor)
American Family Physician ; What is rheumatoid arthritis? Rheumatoid (say: ROO-mah-toyd) arthritis is an autoimmune disease. Usually, your immune system keeps you from getting sick. But if you have an autoimmune disease, your immune system attacks your own body's cells. Joints between bones usually are attacked first. Later,
Quality of Life in American Indian and White Women With and Without Rheumatoid Arthritis
The American Journal of Occupational Therapy ; OBJECTIVE. The purpose of this study was to examine quality of life (QOL) in American Indian and White women with and without rheumatoid arthritis. METHOD. This cross-sectional study included 64 women in four groups: American Indians with rheumatoid arthritis, healthy American Indians, Whites with
Genetics of Rheumatoid Arthritis
Mayo Clinic Proceedings ; Rheumatoid arthritis (RA) is a heterogeneous autoimmune disorder of unknown cause with variable clinical expression. About 70% of patients are women. Genetic factors play an important role and likely account for about 60% of disease susceptibility and expression. The association with the HLA-DRB1
Advances in the treatment of early rheumatoid arthritis.(Editorials)(Editorial)
American Family Physician ; Rheumatoid arthritis is the most common reversible disability in the world, and its economic burden has been estimated to be between $3,600 and $60,300 annually per patient. (1) In this issue of AFP, Drs. Rindfleisch and Muller (2) summarize the approach to the patient with newly diagnosed
Rheumatoid arthritis medication may extend life while easing pain
The Milwaukee Journal Sentinel ; Rheumatoid arthritis medication may extend life while easing pain By EMMA ROSS Associated Press Monday, April 15, 2002 London -- Methotrexate, a key drug for rheumatoid arthritis, could help people with the crippling disease live longer, new research suggests. Methotrexate, originally a cancer
Anti-TNF therapy in early rheumatoid arthritis.(tumor necrosis factor)(Clinical report)
Bandolier ; Anti-TNF therapy for rheumatoid arthritis has a proven high degree of effectiveness (Bandolier 99) in clinical trials and the real world (Bandolier 104). In the main all these patients were already using disease-modifying drugs, or had failed to improve on them. Two new studies [1,2] suggest that